Gyros Protein Technologies specializes in advanced solutions for immunoassays and peptide synthesis, aimed at enhancing productivity and efficiency in laboratory settings. Their Gyrolab technology allows for the execution of immunoassays at a nanoliter scale, significantly reducing the time required to obtain critical insights in various research areas, including biomarker analysis and pharmacokinetics. This technology is particularly beneficial for applications involving monoclonal antibodies and biosimilars, as it supports the analysis of bioprocess impurities and titer quantification, thereby facilitating the development of safer biotherapeutics.

In addition to immunoassay solutions, Gyros Protein Technologies offers innovative peptide synthesizers that streamline the process of solid-phase peptide synthesis (SPPS). These automated systems are designed to meet diverse research needs, from therapeutic development to general research applications. The company’s focus on providing flexible and accurate peptide synthesis solutions enables researchers to achieve their laboratory goals more efficiently, ultimately accelerating breakthroughs in drug discovery and clinical development. Through their comprehensive offerings, Gyros Protein Technologies plays a crucial role in supporting scientific advancements in academia and industry.

Sweden

Gyros Protein Technologies provides enabling peptide synthesis and bioanalytical solutions helping scientists increase biomolecule performance and productivity in pre-clinical/clinical development and bioprocess applications. The automat

Gyros Protein Technologies

Company Details